Purdy, MO—INS Farms announced in a press release that it now has results of the first-ever polyphenol fingerprint testing of the Black Elderberry cultivated in the U.S.
Devon Bennett, CEO of INS Farms, said, “Nobody really knew what was inside this particular berry. The ambiguity in not knowing what exactly constitutes the starting material, we believe, prohibits trustworthy results of human clinical trials.”
Understanding the phytochemical profile of the American-grown berry, he added, allows suppliers to create a standardized starting material for health impact studies—without which, it is impossible to repeat a study with any kind of accuracy. It also helps reduce adulteration, thanks to the fact that companies now know what the material should look like.
Moreover, the fingerprint testing found no difference in the quality or potency of anthocyanins in European Elderberry over American Elderberry—meaning the berry can be grown in America and put to use with no drop in quality.